Repurposing therapeutic agents and herbal medicines to defeat viral nemesis.
作者信息
Caputo Leonardo, Lentini Giovanni, Habtemariam Solomon
机构信息
Institute of Sciences of Food Production (CNR-ISPA), National Council of Research, Bari, Italy.
Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari, Italy.
出版信息
Drug Dev Res. 2020 Sep;81(6):641-642. doi: 10.1002/ddr.21668. Epub 2020 Mar 30.
Abstract
摘要
相似文献
1
Repurposing therapeutic agents and herbal medicines to defeat viral nemesis.重新利用治疗药物和草药以战胜病毒克星。
Drug Dev Res. 2020 Sep;81(6):641-642. doi: 10.1002/ddr.21668. Epub 2020 Mar 30.
2
Repurposing drugs during the COVID-19 pandemic and beyond.在新冠疫情期间及之后对药物进行重新利用。
Pharm Pat Anal. 2021 Jan;10(1):9-12. doi: 10.4155/ppa-2020-0031. Epub 2021 Jan 15.
3
Repurposing antimalarials and other drugs for COVID-19.将抗疟药及其他药物重新用于治疗新冠肺炎。
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
4
COVID-19: Potential Repurposing Drugs.COVID-19：潜在的再利用药物。
Infect Disord Drug Targets. 2022;22(1):e110122191924. doi: 10.2174/1871526521666210301143441.
5
Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases.对抗新敌人的旧武器：药物重新利用以治疗新出现的病毒性疾病
Virol Sin. 2020 Jun;35(3):253-255. doi: 10.1007/s12250-020-00204-7. Epub 2020 Feb 11.
6
Chasing COVID-19 chemotherapeutics without putting the cart before the horse.在不本末倒置的情况下追寻新冠病毒的化疗药物。
Br J Clin Pharmacol. 2023 Jan;89(1):421-423. doi: 10.1111/bcp.14575. Epub 2020 Nov 20.
7
Repurposing Revisited: Exploring the Role of Metformin for Treatment of COVID-19.重新审视药物用途：探索二甲双胍在治疗新冠肺炎中的作用
Clin Infect Dis. 2024 Aug 16;79(2):292-294. doi: 10.1093/cid/ciae154.
8
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19.洛匹那韦、奥司他韦和利托那韦与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）蛋白酶结合用于治疗2019冠状病毒病（COVID-19）的药物重新利用和协同作用的计算研究
J Biomol Struct Dyn. 2021 Apr;39(7):2673-2678. doi: 10.1080/07391102.2020.1752802. Epub 2020 Apr 16.
9
Drug Repurposing: An Alternative Strategy to Treat COVID-19.药物重定位：治疗 COVID-19 的一种替代策略。
Curr Pharm Biotechnol. 2022;23(6):818-827. doi: 10.2174/1389201022666210709141320.
10
Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.经 FDA 批准和正在研究的药物针对 SARS-CoV-2 刺突蛋白和主蛋白酶的再利用潜力，以及通过机器学习算法进行验证。
Chem Biol Drug Des. 2021 Apr;97(4):836-853. doi: 10.1111/cbdd.13812. Epub 2020 Dec 22.
引用本文的文献
1
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study.挖掘严重急性呼吸综合征冠状病毒2非结构蛋白12（SARS-CoV-2 nsp12）抑制剂：基于药效团和分子动力学模拟的研究
Future Virol. 2022 Jul. doi: 10.2217/fvl-2022-0054. Epub 2022 Aug 8.
2
Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives.抗新冠病毒药物：现有药物的再利用或寻找新的复杂实体、策略和前景。
Future Med Chem. 2020 Oct;12(19):1743-1757. doi: 10.4155/fmc-2020-0204. Epub 2020 Jul 23.
本文引用的文献
1
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].[RAS 抑制剂可能是治疗 COVID-19 肺炎的良好选择]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):219-222. doi: 10.3760/cma.j.issn.1001-0939.2020.03.016.
2
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.具有治疗新型呼吸道 2019 冠状病毒潜力的化合物。
Antimicrob Agents Chemother. 2020 Apr 21;64(5). doi: 10.1128/AAC.00399-20.
3
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.将临床批准的药物重新用于治疗 2019 年新型冠状病毒相关冠状病毒模型中的 2019 年冠状病毒病。
Chin Med J (Engl). 2020 May 5;133(9):1051-1056. doi: 10.1097/CM9.0000000000000797.
4
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
5
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
6
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.全长人血管紧张素转化酶 2 识别 SARS-CoV-2 的结构基础。
Science. 2020 Mar 27;367(6485):1444-1448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4.
7
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
8
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
9
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病（COVID-19）？对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
10
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
Zotero 插件